Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Abstract Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed litera...

Full description

Bibliographic Details
Main Authors: Gustavo Citera, Wilson Bautista-Molano, Ingris Peláez-Ballestas, Valderilio F. Azevedo, Risto A. Perich, José A. Méndez-Rodríguez, Mariel S. Cutri, Cecilia E. Borlenghi
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Advances in Rheumatology
Subjects:
Online Access:https://doi.org/10.1186/s42358-020-00161-5
_version_ 1818575380340015104
author Gustavo Citera
Wilson Bautista-Molano
Ingris Peláez-Ballestas
Valderilio F. Azevedo
Risto A. Perich
José A. Méndez-Rodríguez
Mariel S. Cutri
Cecilia E. Borlenghi
author_facet Gustavo Citera
Wilson Bautista-Molano
Ingris Peláez-Ballestas
Valderilio F. Azevedo
Risto A. Perich
José A. Méndez-Rodríguez
Mariel S. Cutri
Cecilia E. Borlenghi
author_sort Gustavo Citera
collection DOAJ
description Abstract Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed literature identified 41 relevant publications. Of these, 11 (mostly based on Mexican data) estimated the prevalence of SpA and its subtypes, which varied from 0.28 to 0.9% (SpA), 0.02 to 0.8% (ankylosing spondylitis), 0.2 to 0.9% (axial SpA), and 0.004 to 0.08% (psoriatic arthritis). Demographic and/or clinical characteristics were reported in 31 of the 41 publications, deriving data from 3 multinational studies, as well as individual studies from Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Uruguay, and Venezuela. Data relating to treatment, disease manifestations (articular and extra-articular), and comorbidities were summarized across the countries. Available data suggest that there is a variability in prevalence, manifestations, and comorbidities of SpA across Latin America. Basic epidemiologic and clinical data are required from several countries not currently represented. Data relating to current treatment approaches, patient outcomes, and socioeconomic impact within this large geographic region are also needed.
first_indexed 2024-12-15T00:39:31Z
format Article
id doaj.art-275bce2f61c94b41a28f0aa6ab2da5e1
institution Directory Open Access Journal
issn 2523-3106
language English
last_indexed 2024-12-15T00:39:31Z
publishDate 2021-01-01
publisher BMC
record_format Article
series Advances in Rheumatology
spelling doaj.art-275bce2f61c94b41a28f0aa6ab2da5e12022-12-21T22:41:41ZengBMCAdvances in Rheumatology2523-31062021-01-0161111210.1186/s42358-020-00161-5Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritisGustavo Citera0Wilson Bautista-Molano1Ingris Peláez-Ballestas2Valderilio F. Azevedo3Risto A. Perich4José A. Méndez-Rodríguez5Mariel S. Cutri6Cecilia E. Borlenghi7Instituto de Rehabilitación PsicofísicaUniversidad Militar Nueva Granada and University Hospital Fundación Santa Fe de BogotáHospital General de México “Dr. Eduardo Liceaga”Universidade Federal do ParanáHospital Nacional Guillermo Almenara IrigoyenHospital La CatólicaPfizerPfizerAbstract Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed literature identified 41 relevant publications. Of these, 11 (mostly based on Mexican data) estimated the prevalence of SpA and its subtypes, which varied from 0.28 to 0.9% (SpA), 0.02 to 0.8% (ankylosing spondylitis), 0.2 to 0.9% (axial SpA), and 0.004 to 0.08% (psoriatic arthritis). Demographic and/or clinical characteristics were reported in 31 of the 41 publications, deriving data from 3 multinational studies, as well as individual studies from Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Uruguay, and Venezuela. Data relating to treatment, disease manifestations (articular and extra-articular), and comorbidities were summarized across the countries. Available data suggest that there is a variability in prevalence, manifestations, and comorbidities of SpA across Latin America. Basic epidemiologic and clinical data are required from several countries not currently represented. Data relating to current treatment approaches, patient outcomes, and socioeconomic impact within this large geographic region are also needed.https://doi.org/10.1186/s42358-020-00161-5PrevalenceSpondyloarthropathyAnkylosing spondylitisPsoriatic arthritisLatin America
spellingShingle Gustavo Citera
Wilson Bautista-Molano
Ingris Peláez-Ballestas
Valderilio F. Azevedo
Risto A. Perich
José A. Méndez-Rodríguez
Mariel S. Cutri
Cecilia E. Borlenghi
Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
Advances in Rheumatology
Prevalence
Spondyloarthropathy
Ankylosing spondylitis
Psoriatic arthritis
Latin America
title Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_full Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_fullStr Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_full_unstemmed Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_short Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis
title_sort prevalence demographics and clinical characteristics of latin american patients with spondyloarthritis
topic Prevalence
Spondyloarthropathy
Ankylosing spondylitis
Psoriatic arthritis
Latin America
url https://doi.org/10.1186/s42358-020-00161-5
work_keys_str_mv AT gustavocitera prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT wilsonbautistamolano prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT ingrispelaezballestas prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT valderiliofazevedo prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT ristoaperich prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT joseamendezrodriguez prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT marielscutri prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis
AT ceciliaeborlenghi prevalencedemographicsandclinicalcharacteristicsoflatinamericanpatientswithspondyloarthritis